Arkolith/Insider Trading/RLAY/Form 4

Bergstrom Donald A

President, R&DRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Oct 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$225K
Net Open-Market Flow
-$225K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Sell(S)31K$7.29$225K522K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-258557) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML